BSX vs ISRG
Boston Scientific (BSX) and Intuitive Surgical (ISRG) compared side by side. Intuitive Surgical (ISRG) is larger, with a market cap of $159.8B versus $66.2B for Boston Scientific, about 2.4 times the size. On trailing earnings, BSX is cheaper at 18.5x versus 54.7x for ISRG.
Head to head
| Metric | BSX | ISRG |
|---|---|---|
| Market cap | $66.2B | $159.8B |
| P/E (TTM) | 18.5x | 54.7x |
| Forward P/E | 13.5x | 36.4x |
| Revenue (TTM) | $21.0B | $11.6B |
| Revenue growth | 7.5% | 21.7% |
| Gross margin | 69.2% | 66.6% |
| Operating margin | 22.9% | 33.3% |
| Free cash flow | $1.8B | $3.2B |
| Dividend yield | None | None |
| 1-year return | -55.4% | -18.0% |
| 5-year return (annual) | +0.4% | +5.8% |
| Max drawdown | -89% | -82% |
| FI Handbook grade | C+ | B |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
BSX vs ISRG FAQ
Which is bigger, BSX or ISRG?
Intuitive Surgical (ISRG) is larger, with a market cap of $159.8B versus $66.2B for Boston Scientific, about 2.4 times the size.
Is BSX or ISRG cheaper?
On trailing earnings, BSX is cheaper at 18.5x versus 54.7x for ISRG. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, BSX or ISRG?
ISRG returned -18.0% over the past year including dividends, versus -55.4% for BSX, through October 23, 2026.
Full pages: Boston Scientific · Intuitive Surgical